Erectile dysfunction (ED) affects millions of men across the United States. While traditional oral medications such as sildenafil (Viagra®), tadalafil (Cialis®), and vardenafil (Levitra®) have been widely prescribed for decades, telehealth innovation and compounding pharmacy practices have expanded the ways clinicians can tailor ED treatment.
QUAD® by MEDVi is a clinician-prescribed compounded formulation designed to combine multiple FDA-approved active ingredients into a single sublingual (under-the-tongue) dose. According to MEDVi, the formula integrates four prescription medications—apomorphine, vardenafil, sildenafil, and tadalafil—to address multiple physiological aspects of erectile performance within one treatment plan.
This article provides a detailed, medically grounded overview of QUAD® by MEDVi, how it works, who it may be appropriate for, potential risks, regulatory considerations, and what patients should discuss with their healthcare provider before considering compounded ED therapies.
Understanding Erectile Dysfunction: A Clinical Overview
Erectile dysfunction is defined as the consistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It can result from a wide range of physical and psychological factors, including:
- Cardiovascular disease
- Diabetes
- Hypertension
- Hormonal imbalances
- Neurological disorders
- Anxiety or depression
- Medication side effects
- Lifestyle factors (smoking, alcohol, obesity)
Because erections depend on healthy blood flow, nerve signaling, hormone balance, and psychological readiness, ED treatment often requires a personalized approach.
First-line therapies typically involve oral phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil or tadalafil. However, not all patients respond equally to single-agent therapy, and some seek longer duration, faster onset, or more flexible timing.
What Is QUAD® by MEDVi?
QUAD® is described by MEDVi as a compounded 4-in-1 prescription medication formulated by licensed U.S. pharmacies and prescribed by U.S.-licensed physicians following telehealth evaluation.
It combines:
- Sildenafil – A PDE5 inhibitor commonly associated with Viagra®
- Tadalafil – A PDE5 inhibitor commonly associated with Cialis®
- Vardenafil – A PDE5 inhibitor commonly associated with Levitra®
- Apomorphine – A dopamine receptor agonist that may influence central arousal pathways
Unlike standard swallowed tablets, QUAD® is formulated as a rapid-absorb sublingual liquid designed to dissolve under the tongue.
It is important to note:
- QUAD® is a compounded medication, meaning it is prepared by a licensed compounding pharmacy.
- Compounded medications are not individually FDA-approved products.
- The individual active ingredients used in compounding may be FDA-approved in other branded or generic forms.
- Compounded medications are typically prescribed when a clinician determines that a patient may benefit from a customized formulation.
Patients should discuss the risks and benefits of compounded medications with their healthcare provider.
Why Combine Four Active Ingredients?
The rationale behind combination therapy in ED management is to address multiple pathways involved in sexual function.
1. PDE5 Inhibitors: Blood Flow Enhancement
Sildenafil, tadalafil, and vardenafil belong to the same drug class (PDE5 inhibitors). They work by:
- Inhibiting phosphodiesterase type 5 (PDE5)
- Increasing cyclic guanosine monophosphate (cGMP)
- Relaxing smooth muscle in penile tissue
- Enhancing blood flow in response to sexual stimulation
Each medication has slightly different pharmacokinetics:
- Sildenafil: Typically works within 30–60 minutes; duration ~4 hours
- Vardenafil: Similar onset; may be slightly faster in some individuals
- Tadalafil: Longer duration; up to 36 hours in some patients
By combining these agents in customized doses, clinicians aim to tailor onset speed, strength, and duration.
However, combining PDE5 inhibitors requires careful medical supervision due to potential side effects and contraindications.
2. Apomorphine: Central Arousal Support
Apomorphine is a dopamine receptor agonist. Unlike PDE5 inhibitors that primarily affect blood flow, apomorphine acts centrally in the brain and may:
- Influence dopamine pathways
- Support sexual desire or arousal mechanisms
- Complement vascular response
Apomorphine has historically been studied in ED treatment but is less commonly used today in standard first-line therapy. In compounded formulations, clinicians may use it to address psychogenic or mixed-origin ED.
Sublingual Delivery: How It Differs from Traditional Pills
QUAD® is formulated as a sublingual liquid, meaning it is administered under the tongue.
How Sublingual Absorption Works
- The medication dissolves under the tongue
- Active ingredients are absorbed through oral mucosa
- This may partially bypass first-pass metabolism in the liver
- It may reduce dependence on gastric digestion
Potential benefits compared to swallowed tablets may include:
- Faster onset in some patients
- Less interference from food intake
- More predictable absorption in certain individuals
However, onset time varies by patient and should not be assumed. Patients should follow their prescribing clinician’s instructions.
Onset and Duration: What Patients Should Realistically Expect
MEDVi states that QUAD® may begin working in as little as 10–15 minutes in some individuals.
Clinically, response time depends on:
- Individual metabolism
- Vascular health
- Underlying cause of ED
- Concurrent medications
- Alcohol intake
- Psychological factors
Tadalafil’s known duration of action may extend up to 36 hours in some patients. This does not mean an erection persists continuously; rather, it indicates a window during which erectile response may be enhanced with sexual stimulation.
Patients should understand:
- PDE5 inhibitors do not cause automatic erections
- Sexual stimulation is still required
- Overuse can increase risk of adverse effects
- Priapism (erection lasting more than 4 hours) requires immediate medical attention
Is Combining Ingredients Safe?
Compounded combination therapies must be prescribed and monitored by licensed healthcare providers.
Potential risks of combining PDE5 inhibitors include:
- Hypotension (low blood pressure)
- Headache
- Flushing
- Dizziness
- Visual disturbances
- Nasal congestion
- Gastrointestinal upset
- Back pain (more common with tadalafil)
Absolute contraindications include:
- Concurrent nitrate use (e.g., nitroglycerin)
- Certain cardiovascular conditions
- Severe hypotension
- Recent stroke or myocardial infarction
- Known hypersensitivity to PDE5 inhibitors
Patients with heart disease, uncontrolled hypertension, diabetes, or other chronic conditions should undergo proper evaluation before ED therapy.
Because compounded medications are customized, dosage accuracy and pharmacy quality standards are critical. MEDVi states it partners with certified U.S. pharmacies.
Patients should confirm:
- Pharmacy accreditation
- State licensure
- Prescribing physician credentials
Telehealth Model: How MEDVi’s Process Works
According to the company’s description, the process includes:
Step 1: Online Evaluation
Patients complete a medical intake form detailing:
- Health history
- Current medications
- Cardiovascular status
- ED severity
- Lifestyle factors
Step 2: Physician Review
A U.S.-licensed doctor reviews the case within approximately 24 hours. If appropriate, a prescription may be issued.
Step 3: Discreet Delivery
The compounded medication is shipped in plain packaging.
Telehealth ED treatment has become increasingly common in the U.S., particularly when:
- Patients prefer privacy
- Access to local specialists is limited
- Follow-up is manageable remotely
However, patients should ensure that the evaluation is thorough and includes screening for cardiovascular risk, as ED can sometimes be an early marker of heart disease.
Cost Considerations
MEDVi lists pricing starting at $119 per month, compared to an indicated retail value of $199.
Cost comparisons should account for:
- Individual medication pricing
- Compounding fees
- Telehealth consultation inclusion
- Shipping costs
- Membership structure
Patients should review:
- Cancellation policies
- Refund terms
- Ongoing subscription commitments
- Insurance coverage (most compounded ED medications are cash-pay)
Comparing QUAD® to Single-Agent ED Medications
Traditional ED prescriptions typically involve one PDE5 inhibitor at a time.
Advantages of Single-Agent Therapy
- Extensive long-term safety data
- FDA approval for specific branded/generic versions
- Clear dosing guidelines
- Insurance coverage potential
Potential Reasons Patients Explore Compounded Combination Therapy
- Incomplete response to single agents
- Desire for faster onset
- Need for longer duration
- Preference for sublingual administration
Combination therapy should always be supervised medically due to cumulative vasodilatory effects.
Who May Be a Candidate?
A clinician may consider combination therapy for:
- Men with moderate to severe ED
- Those who have not achieved satisfactory results from single PDE5 inhibitors
- Individuals seeking longer response windows
- Patients medically cleared for vasodilator therapy
Not appropriate for:
- Men using nitrates
- Severe cardiovascular instability
- Uncontrolled blood pressure
- Severe liver or kidney disease (without physician evaluation)
- History of priapism
The Role of Lifestyle in ED Treatment
Medication alone does not address underlying causes in many cases.
Clinicians often recommend:
- Weight management
- Smoking cessation
- Regular exercise
- Blood sugar control
- Lipid management
- Stress reduction
- Therapy for anxiety or relationship concerns
Because ED may be an early cardiovascular risk marker, comprehensive evaluation is encouraged.
Frequently Asked Questions
Will I have an erection for 36 hours straight?
No. Tadalafil’s duration refers to a responsiveness window, not continuous erection. An erection occurs only with sexual stimulation.
Can I take QUAD® daily?
Dosing frequency must be determined by your prescribing clinician. Overuse may increase risk of side effects.
Is it FDA approved?
Compounded medications are not individually FDA-approved products. The active ingredients used in compounding may be FDA-approved in other formulations.
Can food affect it?
Sublingual administration may reduce food interference compared to swallowed tablets, but response can still vary individually.
Safety First: What to Discuss With Your Doctor
Before starting any ED medication, patients should discuss:
- Full medication list (especially nitrates)
- Cardiovascular history
- Blood pressure
- Diabetes status
- Prior ED treatment response
- Alcohol consumption
- Any history of fainting or arrhythmia
Immediate medical attention is required for:
- Chest pain during sexual activity
- Sudden vision loss
- Hearing loss
- Erection lasting more than 4 hours
Regulatory and Compounding Considerations
Compounded medications:
- Are prepared by licensed compounding pharmacies
- Are intended for patients with specific medical needs
- Are not reviewed by the FDA for safety and efficacy in the same way as branded drugs
- Should be discussed thoroughly with healthcare providers
Patients should confirm pharmacy compliance with state and federal regulations.
Final Thoughts: Is QUAD® by MEDVi Right for You?
QUAD® by MEDVi represents a telehealth-based, compounded combination approach to erectile dysfunction treatment. By integrating multiple PDE5 inhibitors with apomorphine in a sublingual formulation, it aims to address onset time, duration, and central arousal components.
However, ED is often a symptom of broader health conditions. The most effective treatment plan is one that:
- Includes full medical evaluation
- Accounts for cardiovascular risk
- Is supervised by licensed professionals
- Balances efficacy with safety
Men considering compounded ED therapies should consult a qualified healthcare provider to determine whether combination therapy is medically appropriate for their individual health profile.
If you are exploring ED treatment options, speak with a licensed clinician about your symptoms, goals, and health history before starting any medication.
Reviews
There are no reviews yet.